PK AND PD OF GLYBURIDE
PK AND PD OF GLYBURIDE
批准号:
7719044
负责人:
LANE Arie MENACHEM
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2009-03-31
关键词:
Birth traumaComputer Retrieval of Information on Scientific Projects DatabaseDiabetic KetoacidosisDiagnosisDrug KineticsFundingGestational DiabetesGlyburideGrantHyperinsulinismHypertensionHypoglycemiaInfantInfectionInstitutionInsulin ResistanceMetabolicMothersNeonatalNon-Insulin-Dependent Diabetes MellitusPatientsPharmacodynamicsPolyhydramniosPre-EclampsiaPregnancyResearchResearch PersonnelResourcesRiskSourceThird Pregnancy TrimesterUnited StatesUnited States National Institutes of Healthblood glucose regulationdiabeticstillbirth
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
在美国,妊娠期糖尿病(GDM)约占所有妊娠的4%。妊娠期糖尿病类似于2型糖尿病。患有妊娠期糖尿病的母亲所生婴儿有死产、巨大儿(相关出生损伤)、羊水过多和新生儿代谢并发症(如低血糖、胰岛素抵抗、高胰岛素血症)的风险。母亲有感染、高血压、先兆子痫和糖尿病酮症酸中毒的风险。严格的血糖控制降低了母亲和她们的婴儿的风险,但可能与母亲的低血糖有关。格列本脲(Glyburide,GLY)已被用于妊娠期糖尿病的治疗,但对妊娠期该药的药代动力学(PK)和药效学(PD)知之甚少。这项研究将评估妊娠期GLY的PK和PD,并与最近诊断的匹配的2型糖尿病对照组进行比较。假说是格列本脲的药代动力学和药效学在怀孕期间发生了改变。具体目的是:确定格列本脲在妊娠晚期的药代动力学和药效学,并与最近诊断的匹配的2型糖尿病患者进行比较。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Gestational diabetes (GDM) complicates ~4% of all pregnancies in the United States. GDM resembles type 2 diabetes mellitus. Infants born to mothers with GDM are at risk for stillbirth, macrosomia (associated birth injuries), hydramnios and neonatal metabolic complications (e.g. hypoglycemia, insulin resistance, hyperinsulinemia). Mothers are at risk for infections, hypertension, preeclampsia and diabetic ketoacidosis. Tight glucose control reduces risks for mothers and their babies but can be associated with maternal hypoglycemia. Glyburide (GLY) have been used during pregnancy for treatment of GDM however very little is known about the pharmacokinetics (PK) and pharmacodynamics (PD) of this agent during pregnancy. This study will evaluate the PK and PD of GLY during pregnancy as compared to recently diagnosed, matched, type 2 diabetic controls. The hypothesis is that the pharmacokinetics and pharmacodynamics of glyburide are altered during pregnancy. The specific aim is:To determine the pharmacokinetics and pharmacodynamics of glyburide during the third trimester of pregnancy as compared to recently diagnosed, matched, type 2 diabetes mellitus patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A STUDY OF THE PHARMACOLOGY OF 17-HYDROXYPROGESTERONE CAPROATE IN PREGNANCY
-
批准号:7951984
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2009
-
负责人:LANE Arie MENACHEM
-
依托单位:
A STUDY OF THE PHARMACOLOGY OF 17-HYDROXYPROGESTERONE CAPROATE IN PREGNANCY
-
批准号:7719052
-
项目类别:
-
资助金额:$8.28万
-
财政年份:2008
-
负责人:LANE Arie MENACHEM
-
依托单位:
A STUDY OF THE PHARMACOLOGY OF 17-HYDROXYPROGESTERONE CAPROATE IN PREGNANCY
-
批准号:7608328
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2006
-
负责人:LANE Arie MENACHEM
-
依托单位:
PK AND PD OF GLYBURIDE
-
批准号:7608314
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2006
-
负责人:LANE Arie MENACHEM
-
依托单位: